Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain
- PMID: 36233576
- PMCID: PMC9571737
- DOI: 10.3390/jcm11195708
Survival of Breast Cancer by Stage, Grade and Molecular Groups in Mallorca, Spain
Abstract
The aims of this study are: (1) to determine cause-specific survival by stage, grade, and molecular groups of breast cancer, (2) to identify factors which explain and predict the likelihood of survival and the risk of dying from this cancer; and (3) to find out the distribution of breast cancer cases by stage, grade, and molecular groups in females diagnosed in the period 2006-2012 in Mallorca (Spain). We collected data regarding age, date and diagnostic method, histology, laterality, sublocation, pathological or clinical tumor size (T), pathological or clinical regional lymph nodes (N), metastasis (M) and stage, histologic grade, estrogen and progesterone receptors status, HER-2 expression, Ki67 level, molecular classification, date of last follow-up or date of death, and cause of death. We identified 2869 cases. Cause-specific survival for the entire sample was 96% 1 year after diagnosis, 91% at 3 years and 87% at 5 years. Relative survival was 96.9% 1 year after diagnosis, 92.6% at 3 years and 88.5% at 5 years. The competing-risks regression model determined that patients over 65 years of age and patients with triple negative cancer have worse prognoses, and as stages progress, the prognosis for breast cancer worsens, especially from stage III.
Keywords: breast cancer; competing-risks regression model; multiple imputation; survival.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



References
-
- Cancer Today. [(accessed on 13 March 2022)]. Available online: https://gco.iarc.fr/today/home.
-
- Redecan. [(accessed on 13 March 2022)]. Available online: https://redecan.org/es.
-
- Sant M., Lopez M.D.C., Agresti R., Pérez M.J.S., Holleczek B., Bielska-Lasota M., Dimitrova N., Innos K., Katalinic A., Langseth H., et al. Survival of women with cancers of breast and genital organs in Europe 1999–2007: Results of the EUROCARE-5 study. Eur. J. Cancer. 2015;51:2191–2205. doi: 10.1016/j.ejca.2015.07.022. - DOI - PubMed
-
- Chirlaque M.D., the REDECAN Working Group. Salmerón D., Galceran J., Ameijide A., Mateos A., Torrella A., Jiménez R., Larrañaga N., Marcos-Gragera R., et al. Cancer survival in adult patients in Spain. Results from nine population-based cancer registries. Clin. Transl. Oncol. 2018;20:201–211. doi: 10.1007/s12094-017-1710-6. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous